Sodium chloride and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sodium chloride (sodium chloride) and Repaglinide (repaglinide). Common drug interactions include sepsis among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Sodium chloride and Repaglinide. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Sodium chloride?

Sodium chloride has active ingredients of sodium chloride. eHealthMe is studying from 39,559 Sodium chloride users. Check the latest studies of Sodium chloride.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.



On Jul, 06, 2026

34 people who take Sodium chloride and Repaglinide together, and have interactions are studied.

Sodium chloride and Repaglinide drug interactions.

What are the common drug interactions of Sodium Chloride and Repaglinide, by gender? *:

female:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Chronic kidney disease
  3. Dyspepsia (indigestion)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Renal failure (kidney dysfunction)
  9. Renal injury (kidney injury)
  10. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

male:

  1. Renal failure (kidney dysfunction)
  2. Mesenteritis (inflammation of the mesentery)
  3. Upper respiratory tract infection
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. Insomnia (sleeplessness)
  7. Leukopenia (less number of white blood cells in blood)
  8. Mucosal inflammation (infection of mucous membrane)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Thrombocytopenia (decrease of platelets in blood)

What are the common drug interactions of Sodium Chloride and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  2. Pulmonary haemorrhage (acute bleeding from the lung)

40-49:

n/a

50-59:

  1. Myelosuppression (a decrease in the production of blood cells)
  2. Pneumonia
  3. Chronic kidney disease
  4. Dyspepsia (indigestion)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Renal failure (kidney dysfunction)
  10. Renal injury (kidney injury)

60+:

  1. Renal failure (kidney dysfunction)
  2. Mesenteritis (inflammation of the mesentery)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Fatigue (feeling of tiredness)
  6. Leukopenia (less number of white blood cells in blood)
  7. Mucosal inflammation (infection of mucous membrane)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Angioedema (rapid swelling of the dermis)

What are the existing conditions these people have? *

  1. High Blood Pressure: 13 people, 38.24%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 20.59%
  3. Urination - Excessive Volume: 6 people, 17.65%
  4. Type 2 Diabetes: 6 people, 17.65%
  5. Enlarged Prostate: 5 people, 14.71%
  6. Nausea (feeling of having an urge to vomit): 4 people, 11.76%
  7. Blood Albumin Increased: 4 people, 11.76%
  8. Blood Glucose Decreased: 4 people, 11.76%
  9. Anaemia (lack of blood): 4 people, 11.76%
  10. Platelet Count Increased: 4 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Sodium chloride and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sodium chloride and Repaglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sodium chloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Repaglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sodium chloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Repaglinide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sodium chloride and repaglinide (the active ingredients of Sodium chloride and Repaglinide, respectively), and Sodium chloride and Repaglinide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: